Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/22/24
End: 09/21/24
Due: 09/21/25
Phase: N/A
Priority: Normal
Start: 04/15/22
End: 12/25/22
Due: 12/25/23
Phase: N/A
Priority: Normal
Start: 11/10/21
End: 01/05/22
Due: 01/05/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of PA9159 Inhalation Aerosol in Healthy Adult Subjects | NCT06916273 | Anhui Palo Alto Pharmaceuticals, Inc. | user2@example.com | None | 2024-07-22 | 2024-09-21 | 2025-09-21 | - | - | 2025-07-14 |
| Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis | NCT05234580 | Anhui Palo Alto Pharmaceuticals, Inc. | user2@example.com | None | 2022-04-15 | 2022-12-25 | 2023-12-25 | - | - | 2025-07-14 |
| Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects | NCT05170763 | Anhui Palo Alto Pharmaceuticals, Inc. | user2@example.com | None | 2021-11-10 | 2022-01-05 | 2023-01-05 | - | - | 2025-07-14 |